• Eastman’s Q2 2026 earnings call drew CEO Mark Costa, CFO William McLain, IR head Gregory Riddle, analysts from Citi, UBS, Deutsche Bank, JPMorgan, Morgan Stanley, Wells Fargo, Mizuho, BofA, Jefferies.
• Costa flagged no expected recovery in weak discretionary markets in 2H 2026; stable markets provide modest growth; no material demand hit yet from the Middle East war.
• Advanced Materials volumes expected roughly flat sequentially in Q3; year-on-year increase driven by innovation wins, Renew ramp, utilization tailwinds, price-cost turning favorable.
• Renew sales growth expected to exceed $100 million in 2026; evenly split between specialty growth and rPET; demand slowdown and rPET supply constraints both trimmed outlook.
• Costa reiterated Kingsport methanolysis first-asset target of $200 million EBITDA; plant yields above 90%; debottleneck potential to 130% capacity; next major spend pushed to 2028.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eastman Chemical Company published the original content used to generate this news brief on July 31, 2026, and is solely responsible for the information contained therein.